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Abstract
Background: Many metabolic changes develop in patients with chronic kidney disease which often necessitate
frequent biochemical analysis of blood. Saliva analysis as an alternative to blood has many advantages. The aims of
this study were to evaluate levels of salivary creatinine and urea in patients with chronic kidney disease in comparison
to healthy individuals; to determine correlation between salivary creatinine/urea and blood creatinine/urea and to
evaluate the diagnostic potential of saliva.
Methods: A case control study, involving 50 patients with late stage chronic kidney disease and 49 healthy individuals
as control. Blood and saliva samples were analyzed for urea and creatinine levels. Data are presented as median with
interquartile range and compared using Independent Samples Mann Whitney U test. Correlation between plasma and
salivary creatinine as well as urea was determined using Spearman’s correlation test. Receiver operating characteristics
(ROC) analysis was done to determine the diagnostic ability of salivary creatinine and urea and cut-off values were
established.
Results: Median salivary creatinine levels were 2.60 mg/dl and 0.20 mg/dl while median salivary urea levels
were 92.00 mg/dl and 20.50 mg/dl in patients with chronic kidney disease and controls respectively. Salivary
levels of creatinine and urea were significantly elevated in chronic kidney disease patients (p < 0.001). In addition, there
was positive correlation between blood and salivary creatinine as well as urea levels. Total areas under the curve for
salivary creatinine and urea were 0.97 and 0.89 respectively. Cut-off values for salivary creatinine and urea were 0.55 mg/dl
and 27.50 mg/dl respectively which gave sensitivity and specificity of 94 % and 85 % for creatinine; as well as 86 % and
93 % for urea.
Conclusions: Findings of this study suggest that analysis of salivary creatinine and urea in patients with chronic kidney
disease reflects their levels in blood. Hence, salivary creatinine and urea could be used as diagnostic biomarkers of chronic
kidney disease.
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Background
Worldwide, increasing numbers of patients are affected
by chronic kidney disease (CKD) [1, 2]. The progressive
nature of CKD and the ensuing end stage renal disease
(ESRD) is putting a substantial burden on global health-
care resources [3]. Chronic kidney disease is associated
with accumulation of metabolic waste products and
multi organ involvements. These changes usually mani-
fest as elevated blood urea and creatinine as well as
hematologic, electrolyte, endocrine and skeletal disor-
ders [4].
Several systemic diseases have been reported to pro-
duce marked and identifiable changes in salivary secre-
tion [5–8]. Chronic kidney disease is one of the systemic
diseases that can affect the contents of salivary secre-
tions. More importantly, saliva can indicate creatinine
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and urea levels in patients with CKD which are the pa-
rameters usually assessed in blood samples. Analysis of
salivary creatinine and urea in patients with CKD offers
many advantages that have been attributed to the use of
saliva as a diagnostic fluid.
Use of blood for diagnostic tests is an invasive process
usually associated with nervousness and distress to the
patients. Also, some form of blood loss is commonly re-
lated to procedures like hemodialysis and frequent blood
sampling in chronic kidney disease patients [9]. In
addition, the individuals involved in the management of
CKD patients are at more risk of blood borne diseases.
Hence, a non-invasive diagnostic test with minimal risk
with ability to provide a dependable evaluation of disease
condition would be of worth to both the health profes-
sionals and the patients.
Saliva as a biologic fluid secreted by the major and
minor salivary glands plays the main role in oral health
as well as systemic health. It has many advantages over
serum because its collection is non invasive, simple, and
requires minimal skill. Saliva sampling is appropriate for
all age groups and can be repeated more frequently. It
also offers a cost-effective method for the screening of
large populations [10, 11].
Parameters in saliva can be affected by many factors
including diet and genetics. Because of this, use of saliva
as a diagnostic fluid is still subject to continuous re-
search. This study was therefore designed to assess levels
of salivary creatinine and urea; to determine the correl-
ation between the levels in saliva and blood as well as to
evaluate the diagnostic potential of saliva in assessing
levels of creatinine and urea in patients with CKD.
Methods
Study design
This was a cross sectional survey of patients with CKD
attending a tertiary hospital and healthy individuals as
controls.
Study population
The study received ethical clearance and approval
from the institution Research Ethics Committee (Uni-
versity of Ibadan/University College Hospital Ethics
Committee/13/0099). Patients with CKD were individ-
uals diagnosed of the disease having estimated GFR
of < 60 ml/min/1.73 m2 and stages 4 and 5 of
National Kidney Foundation – Kidney Disease Out-
come Quality Initiative (NKF-KDOQI) staging. The
etiologies of CKD in the patients were hypertension,
chronic glomerulonephritis, obstructive uropathy and
diabetes mellitus. Most of the patients with CKD
were undergoing dialysis treatment because of their
late stage presentation. Also included in the study
were the healthy controls who were volunteers and
had no history of kidney disease, systemic or oral dis-
ease. Participants were provided information regarding
risks and benefit of the study and verbal consent was
taken. Participants had oral examination before saliva
collection.
Sample size
The minimum required sample size was calculated using
the estimated means of salivary urea in a known test and
control [12] with the standard normal values set at 0.05
and a power of 90 %. The calculated minimum sample
size for each group was rounded up to 40 participants
including 20 % attrition. Therefore, we included 99 par-
ticipants (50 patients with CKD and 49 healthy controls)
comprising 60 females and 39 males with a mean age of
39.45 years (range: 17 to 70 years). Patients with CKD
were in stages 4 (12 %) and 5 (88 %). The demographic
data of the patients with CKD and the healthy controls
is shown in Table 1.
Saliva and blood sampling
Saliva collection was undertaken throughout the day
(between 9.00 h and 16.00 h) and participants had not
had meal for at least 2 h before saliva collection. Whole
saliva was collected by spitting method. Participants
were asked to spit (after rinsing the mouth with distilled
water) into calibrated universal plastic bottles until
about 3 mls of saliva was collected. Saliva samples were
stored at -20 °C until laboratory analysis. Samples were
defrosted at room temperature and then centrifuged at
3000 rpm for 10 min before being used for the analysis
in order to remove contaminants. Simultaneously, 5mls
of blood samples were taken from the participants by
venipuncture into lithium heparin bottles and the
plasma was used for the analysis.
Analysis of plasma and salivary creatinine and urea
Plasma and salivary creatinine levels were determined
using modified Jaffe’s method [13] while urea levels were
estimated using the method employed by Marsh et al.
[14]. The methods involved colorimetric determination
of creatinine levels using creatinine Assay Kit from
RANDOX Reagents (USA) following manufacturer’s
Table 1 Demographic of patients with CKD and healthy
controls
CKD patients Healthy controls
N 50 49
Age (years) 39.82 ± 11.07, 39.07 ± 7.64,
Range: 17 to 68 Range: 19 to 70
Male 20 19
Female 30 30
N Number of participants; Age is presented as mean ± SD
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instructions. Levels of urea were also determined using
Urea Assay Kit from RANDOX Reagents (USA). The ab-
sorbance was measured at 510 nm and 580 nm for cre-
atinine and urea respectively using spectrophotometer-
300 (ThermoScientific, USA). These methods have been
standardized for saliva in previous studies [12, 15].
Statistical analysis
The descriptive statistics of the participants’ demo-
graphic data are given as the mean and standard devi-
ation while those of salivary creatinine and urea are
presented as median and interquartile range. The out-
come variables were median values of salivary creatinine
and urea in patients with CKD and healthy controls.
Values of salivary creatinine and urea were compared
using Independent Samples Mann Whitney U Test
(non-parametric test) because data was not normally dis-
tributed. Correlation between plasma and salivary urea
as well as creatinine was assessed using Spearman’s cor-
relation test. Linear regression equations were derived to
estimate the plasma level of creatinine as well as urea
from the salivary levels. Receiver Operating Characteris-
tic (ROC) analysis was performed to evaluate the diag-
nostic potential of salivary creatinine and urea compared
to blood and to correctly separate the participants into
cases and controls i.e. to find whether salivary creatinine
as well as urea levels can distinguish patients with CKD
from healthy individuals (controls). The overall perform-
ance was assessed by the Total area under the curve and
the cut-off values were determined based on the best
trade-off between the sensitivity and specificity. All
analysis was done using SPSS (version 22) and level of
statistical significance was set at p < 0.05.
Results
Plasma creatinine and urea levels are shown in Table 2. As
expected the median plasma creatinine and urea were sig-
nificantly higher in patients with CKD (p < 0.001).
Correlation between plasma and salivary creatinine as
well as urea showed a significant positive relationship
(Table 3). Linear regression analysis performed to esti-
mate plasma creatinine as well as urea levels in saliva
showed the equations indicated in Figs. 1 and 2.
To evaluate the diagnostic potential of salivary urea
compared to plasma urea, i.e. to correctly separate the
groups into cases and controls, ROC analysis (Fig. 3)
was performed. Total area under the curve was 0.89
(Standard Error = 0.04, p-value < 0.001, 95 % confidence
interval = 0.81–0.97). Sensitivity and specificity for differ-
ent values of salivary urea were established and a cut-off
was determined (Table 4).
Similarly, to evaluate the diagnostic potential of saliv-
ary creatinine compared to plasma creatinine, i.e. to cor-
rectly separate the groups into cases and controls, ROC
analysis (Fig. 4) was performed. Total area under the
curve was 0.97 (Standard Error = 0.01, p-value < 0.001,
95 % confidence interval = 0.944–0.998).
Sensitivity and specificity for different values of saliv-
ary creatinine were established and a cut-off value was
determined (Table 5).
Discussion
In this study, patients with CKD showed elevated levels
of salivary creatinine and urea compared to the levels in
healthy individuals. In addition, the salivary levels of
creatinine and urea showed positive correlation with
the levels in plasma. Our findings are consistent with
previous reports [15–17] adding to the existing data
to support the possibility of employing analysis of
Table 2 Plasma and salivary creatinine and urea levels in
patients with CKD and healthy controls
CKD patients Healthy controls P value
Plasma (mg/dl) Creatinine 10.45 (5.85), 1.15 (0.42) <0.001
Urea 138.50 (126.00) 24.50 (13.25) <0.001
Saliva (mg/dl) Creatinine 2.60 (1.95) 0.20 (0.15) <0.001
Urea 92.00 (139.00) 20.50 (8.00) <0.001
Note: Data are presented as median (interquartile range), n = 50 for patients
with CKD, n = 49 for healthy controls
Table 3 Correlation between plasma and salivary creatinine and
urea levels in patients with CKD and healthy controls
Creatinine Urea
Spearman’s rho 0.69 0.51
P value 0.00 0.00
N 99 99
N Number of participants
Fig. 1 Correlation between salivary and blood creatinine levels in
patients with CKD and healthy controls, n = 99
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salivary creatinine and urea for the diagnosis and as-
sessment of CKD.
The elevated levels of salivary creatinine and urea
observed in patients with CKD are reflections of the
blood levels as confirmed by the positive correlations.
These elevated salivary levels of creatinine and urea
could be responsible for the complaints of dry mouth
[18], mouth odour or uremic breath [19] as well as
tongue coating and other oral complications [20] of
CKD. The uremic fetor, an ammoniacal odor from
the mouth is a typical sign of uremic patients which
is caused by the high concentration of urea in the
saliva and its subsequent breakdown to ammonia
[21]. Similarly, the positive correlation between serum
and salivary creatinine observed in this study could be ex-
plained by the increased concentration of creatinine and
urea in patients with CKD which creates a concentration
gradient that facilitates increased diffusion of creatinine
and urea from serum into saliva [22].
The positive correlation between blood and salivary
urea as well as creatinine observed in this study agrees
with previous reports [14, 23, 24]. In addition, a study by
Tomas et al. [12] reported that concentrations of salivary
urea were related to the severity of the kidney disease,
and another study also showed that the concentration
decreased with haemodialysis [25]. These suggest that
analysis of salivary urea and creatinine could be an ap-
propriate method for monitoring the efficacy of haemo-
dialysis and progression of the CKD in addition to the
use in the diagnosis of the condition.
Before salivary analysis of urea and creatinine can be
adopted as a diagnostic method to replace the use of
Fig. 2 Correlation between salivary and blood urea levels in patients
with CKD and healthy controls, n = 99
Fig. 3 ROC curve for salivary urea levels. Total area under the curve
for salivary urea is 0.89
Table 4 Coordinates of the ROC curve for salivary urea





Bolded data indicate the cut-off value for salivary urea based on the best trade
off between sensitivity and specificity
Fig. 4 ROC curve for salivary creatinine levels. Total area under the
curve for salivary creatinine is 0.97
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blood, the diagnostic value of the new salivary test must
be compared with the available standard methods [16].
The accuracy of the new test depends on how well it
separates the group being tested into those with the dis-
ease or without the disease [26]. Sensitivity and specifi-
city are the basic methods to determine the accuracy of
a diagnostic test. Hence ROC analysis is used to ascer-
tain the diagnostic potential of a tool (in this case saliva)
as an alternative to a standard method (in this case
blood). The ROC analysis of salivary creatinine and urea
in our study showed a good accuracy with good sensitiv-
ity and specificity. Our finding is in agreement with
those reported by Ventakapathy et al. [16]. Thus, it im-
plies that individuals with salivary creatinine as well as
urea values above the cut-off values are more likely to
suffer from CKD hence need further evaluation for ap-
propriate management. In addition, the findings from
the present study adds to the existing data that saliva
can be used as alternative diagnostic fluid for estimating
blood creatinine and urea in patients with CKD.
Some factors like age, gender, time of the day and meal
affect salivary secretion. These factors must be consid-
ered in salivary analysis for it to be accepted as a diag-
nostic tool in assessing CKD patients. Some of these
factors were also considered in the present study. In our
study, saliva samples were taken throughout the day be-
cause studies by Peng et al. [15] and Cardoso et al. [27]
have demonstrated that salivary urea has comparable
concentration in the morning and afternoon. This im-
plies that salivary urea does not significantly change dur-
ing the day. They also suggested that salivary urea
concentration is independent of saliva volume and de-
tection of salivary urea can be done at any time during
the day. In addition, it is particularly useful to monitor
the condition of patients with CKD at all times, without
the challenge of frequent blood sampling.
In our study, age matched healthy individuals were in-
cluded as controls because studies [28, 29] have shown
that age affects levels of blood as well as salivary urea.
Renal function regresses gradually after a certain age like
all other organs, so also the glomerular filtration rate
leading to slight increase in blood and salivary urea as
well as creatinine.
The general values for creatinine and urea in our
study were higher than those reported by previous studies
[15, 16, 24]. The variations can be attributed to the differ-
ent populations, locations as well as ages of the partici-
pants. In addition, the higher levels of creatinine and urea
observed in our study could be explained by the higher
percentage of patients with CKD in stages 4 and 5.
One limitation of this study is the inclusion of patients
in stages 4 and 5 of CKD (with higher proportion of
stage 5 patients) only which was not intentional but
could be explained by the late presentation of patients in
our environment due to sociocultural and economic fac-
tors [30]. This also hindered the analysis of relationships
between salivary levels of creatinine and urea with the
stage of CKD. Another limitation of this study is the lack
of different cut-off values depending on sex and age
which could be explained by the sample size.
Conclusions
Findings from our study demonstrated elevated levels of
salivary creatinine and urea with positive correlation to
the levels in blood in patients with late stage CKD. In
addition, ROC analysis showed good sensitivity and
specificity values of salivary creatinine and urea. This
supports the possibility of using saliva in the diagno-
sis and monitoring of patients with CKD. However
patients in the early and moderate stages of the dis-
ease must be included in other studies in order to
consider salivary creatinine and urea measurement as
a diagnostic tool for CKD.
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